Antibiotics Market to reach USD 65.23 billion by 2032, growing at a CAGR of 3.70% from 2024-2032.
The antibiotics market worldwide is on the rise, fueled by increasing global cases of infectious diseases coupled with heightened concerns over antimicrobial resistance (AMR), giving way to a flourishing antibiotics market. AMR is expected to kill as many as 10 million people each year by 2050 unless new antibiotics are developed in time. As a result, this scenario leads to an estimated 154 million antibiotic prescriptions per year at outpatient visits in the United States alone. This statistic highlights the need for both auditing of and reduced access to antibiotics in addressing AMR. This mounting need points to a global health crisis that calls for action and intervention.